VBI Vaccines Inc expected to post a loss of 22 cents a share - Earnings Preview

VBI Vaccines

08/03/2024 13:26

* VBI Vaccines Inc  VBIV.OQ   VBIV.O  is expected to show a
rise
in quarterly revenue when it reports  results on March 11
(estimated) for the period ending December 31 2023
    * The Cambridge Massachusetts-based  company is expected to
report
a 1,729.4% increase in revenue to $5.36 million from $293
thousand a year ago, according to the estimate from one analyst,
based on LSEG data.
    * ​LSEG's mean analyst estimate for VBI Vaccines Inc is for
a loss
of 22 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for VBI
Vaccines Inc
is $4.00​, above​ its last closing price of $0.58. ​​​

This summary was machine generated March 8 at 13:26 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)